Is there a Future for Cyclo-Oxygenase Inhibitors in Alzheimer's Disease?

By Ho Lap   Qin Weiping   Stetka Breton S.   Pasinetti Giulio M.  

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 85-98

Adis International

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 Inhibitors and the Kidney: A Case for Caution

By Noroian G.   Clive D.  

Drug Safety, Vol. 25, Iss. 3, 2002-01 ,pp. : 165-172

Adis International

Access to resources Recommend Favorite

Potential therapeutic targets for Alzheimer’s disease

By McKeon-O’Malley C.   Saunders A.J.   Bush A.I.   Tanzi R.E.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 157-179

Informa Healthcare

Access to resources Recommend Favorite

Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 13, 2015-09 ,pp. : 1110-1121

Bentham Science Publishers

Access to resources Recommend Favorite

Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease

By Beher Dirk   Graham Samuel L  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1385-1409

Informa Healthcare

Access to resources Recommend Favorite